Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

VRTX Vertex Pharmaceuticals Inc
$467.50 -0.21% -1.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy VRTX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 119.2B
Enterprise value 114.9B
Trailing PE 30.67906
Forward PE 21.489698
PEG Ratio 0.95535669298246
Enterprise to EBITDA 23.613
Enterprise to revenue 9.574
Price to book MRQ 6.3996463
Price to sales TTM 9.953816

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 12.0B
EBITDA 5.2B
Diluted EPS TTM 15.33
Total Cash (MRQ) 6.6B
Current ratio (MRQ) 2.901
Operating Cash Flow (TTM) 3.6B

VRTX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent VRTX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.